New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 28, 2012
07:34 EDTCPHDCepheid 2013 sales of CT/NG estimated $15M-$20M at William Blair
William Blair expects solid initial demand for Cepheid's just approved Xpert CT/NG from existing Xpert customers and projects 2013 sales between $15M-$20M on a worldwide basis. However, William Blair says it is not sure if Cepheid will be able to ship enough product to meet initial demand as it provided no update on the recent manufacturing issues. The firm keeps an Outperform rating on the stock.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 24, 2014
16:07 EDTCPHDCepheid announces FDA clearance for flu test
Subscribe for More Information
November 14, 2014
12:37 EDTCPHDCepheid management to meet with Jefferies
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use